| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 15 |
| 1 | ASPIRIN 325 MG | 15 |
| 2 | ASPIRIN 81 MG | 15 |
| 3 | ATORVASTATIN CALCIUM | 10 |
| 4 | GABAPENTIN | 10 |
| 5 | LEVOTHYROXINE SODIUM | 9 |
| 6 | BEVACIZUMAB | 8 |
| 7 | FISH OIL | 8 |
| 8 | FOLIC ACID | 8 |
| 9 | BUPROPION HYDROCHLORIDE | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HALCINONIDE | 3 | 0.0155 |
| 1 | AVOBENZONE, HOMOSALATE, OCTISALAT, OCTOCRYLENE | 1 | 0.0071 |
| 2 | AVOBENZONE, HOMOSALATE, OCTOCRYLENE, OCTISALATE | 1 | 0.0067 |
| 3 | BUPROPION HCL ER | 2 | 0.0043 |
| 4 | TITANIUM DIOXIDE | 1 | 0.0041 |
| 5 | TRASTUZUMAB-DKST | 1 | 0.0036 |
| 6 | GADOPICLENOL | 1 | 0.0036 |
| 7 | TETRACAINE | 1 | 0.0025 |
| 8 | AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE | 1 | 0.0022 |
| 9 | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | 2 | 0.0018 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 23 |
| 1 | Platelet Aggregation Inhibitor [EPC] | 16 |
| 2 | Corticosteroid [EPC] | 13 |
| 3 | Angiotensin 2 Receptor Blocker [EPC] | 11 |
| 4 | HMG-CoA Reductase Inhibitor [EPC] | 10 |
| 5 | Vitamin C [EPC] | 10 |
| 6 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 9 |
| 7 | Prostaglandin Analog [EPC] | 8 |
| 8 | Vitamin B12 [EPC] | 8 |
| 9 | Vitamin D [EPC] | 8 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Sclerosing Agent [EPC] | 1 | 0.0022 |
| 1 | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] | 1 | 0.0012 |
| 2 | Quinolone Antimicrobial [EPC] | 5 | 0.0005 |
| 3 | Plasma Volume Expander [EPC] | 1 | 0.0003 |
| 4 | alpha-1 Adrenergic Agonist [EPC] | 1 | 0.0002 |
| 5 | Paramagnetic Contrast Agent [EPC] | 1 | 0.0002 |
| 6 | Carbonic Anhydrase Inhibitor [EPC] | 3 | 0.0001 |
| 7 | Vitamin D2 Analog [EPC] | 1 | 0.0001 |
| 8 | Anticholinergic [EPC] | 2 | 0.0001 |
| 9 | Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] | 2 | 0.0001 |